Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.22% |
| 2 | Healthcare | 7.51% |
| 3 | Financials | 7.44% |
| 4 | Industrials | 5.79% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
3151
PUT
DELISTED
Select Medical
SEM
| $3.1M | ﹤0.01% |
+232,000
| New | +$3M |
|
|
USER
3152
DELISTED
UserTesting, Inc.
USER
| $3.1M | ﹤0.01% |
+413,369
| New | +$2.64M |
|
3153
Virgin Galactic
SPCE
$398M
| $3.1M | ﹤0.01% |
+44,555
| New | +$4.16M |
|
3154
Beam Therapeutics
BEAM
$2.84B
| $3.1M | ﹤0.01% |
79,154
-88,951
| -53% | -$3.98M |
|
3155
PUT
IAMGOLD
IAG
$10.5B
| $3.1M | ﹤0.01% |
1,200,000
-500,000
| -29% | -$869K |
|
|
LIVB
3156
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
| $3.1M | ﹤0.01% |
301,700
-8
| -0% | -$81 |
|
3157
JetBlue
JBLU
$2.29B
| $3.08M | ﹤0.01% |
475,748
-297,225
| -38% | -$2.17M |
|
3158
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $3.08M | ﹤0.01% |
40,963
-1,100
| -3% | -$82.2K |
|
3159
BCB Bancorp
BCBP
$161M
| $3.08M | ﹤0.01% |
171,055
+44,900
| +36% | +$841K |
|
3160
Ryder
R
$10.1B
| $3.07M | ﹤0.01% |
36,709
-178,156
| -83% | -$15M |
|
|
CMRC
3161
CALL
Commerce.com Inc Series 1
CMRC
$184M
| $3.06M | ﹤0.01% |
350,000
+100,000
| +40% | +$1.08M |
|
3162
Radware
RDWR
$1.19B
| $3.06M | ﹤0.01% |
154,911
+134,940
| +676% | +$2.82M |
|
3163
FormFactor
FORM
$9.17B
| $3.05M | ﹤0.01% |
137,029
-262,358
| -66% | -$6.11M |
|
3164
PUT
Spectrum Brands
SPB
$2.07B
| $3.05M | ﹤0.01% |
+50,000
| New | +$2.52M |
|
|
CELL
3165
DELISTED
PhenomeX Inc. Common Stock
CELL
| $3.04M | ﹤0.01% |
1,136,261
+1,050,046
| +1,218% | +$2.77M |
|
3166
Donnelley Financial Solutions
DFIN
$1.16B
| $3.02M | ﹤0.01% |
78,205
-11,050
| -12% | -$414K |
|
|
FNA
3167
DELISTED
Paragon 28, Inc.
FNA
| $3.02M | ﹤0.01% |
158,204
-606,778
| -79% | -$11.5M |
|
|
BYTSU
3168
DELISTED
BYTE Acquisition Corp. Units
BYTSU
| $3.02M | ﹤0.01% |
300,000
| – | – |
|
3169
Northern Trust
NTRS
$33.9B
| $3M | ﹤0.01% |
33,938
-308,321
| -90% | -$27M |
|
|
CFIV
3170
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $3M | ﹤0.01% |
299,027
+26,645
| +10% | +$267K |
|
3171
H.B. Fuller
FUL
$3.28B
| $2.99M | ﹤0.01% |
+41,794
| New | +$3.02M |
|
3172
Monte Rosa Therapeutics
GLUE
$1.35B
| $2.99M | ﹤0.01% |
393,150
+367,221
| +1,416% | +$3.06M |
|
|
HOLX
3173
CALL
DELISTED
Hologic
HOLX
| $2.99M | ﹤0.01% |
40,000
-310,000
| -89% | -$22.1M |
|
3174
Arcus Biosciences
RCUS
$3.64B
| $2.99M | ﹤0.01% |
144,627
+132,066
| +1,051% | +$3.63M |
|
|
BBBY
3175
Bed Bath & Beyond
BBBY
$442M
| $2.98M | ﹤0.01% |
169,131
+130,383
| +336% | +$2.8M |
|
Similar funds
Millennium Management's Q4 2022 Portfolio in Review
As of Q4 2022, Millennium Management held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management's Q4 2022 filing shows 848 new, 2,517 increased, 2,492 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Millennium Management added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Millennium Management's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Millennium Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Millennium Management's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Millennium Management opened 848 new positions and closed 1,332 in Q4 2022.
- Millennium Management's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.